Protein transfer enhances cellular immune responses to DNA vaccination against SARS-CoV

Viral Immunology

Volumn 22, Issue 6, 2009, Pages 417-422

  Kang, Youmin ^a   Chen, Aoshuang ^b   Wang, Bin ^a   Zheng, Guoxing ^b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 LIGAND; DNA VACCINE; LIPID; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL MEMBRANE; CELLULAR IMMUNITY; CONJUGATE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; DRUG EFFICACY; INJECTION SITE; LYMPHOCYTE PROLIFERATION; MOUSE; MUSCLE CELL; NONHUMAN; PROTEIN TRANSPORT; SARS CORONAVIRUS; T LYMPHOCYTE ACTIVATION;

4-1BB LIGAND; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIGEN-PRESENTING CELLS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NUCLEOCAPSID PROTEINS; PALMITIC ACID; RECOMBINANT FUSION PROTEINS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STAPHYLOCOCCAL PROTEIN A; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA;

MUS; SARS CORONAVIRUS;

EID: 71449118351     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2009.0048     Document Type: Article

References (30)

1. Chen A, Zheng G, and Tykocinski ML: Hierarchical costimulator thresholds for distinct immune responses: Application of a novel two-step Fc fusion protein transfer method. J Immunol 2000;164:705-711.
2. Chen Z, Pei D, Jiang L, et al.: Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin Chem 2004;50:988-995.
3. Croft M: Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol 2003;3:609-620.
4. Goebels N, Michaelis D, Wekerle H, and Hohlfeld R: Human myoblasts as antigen-presenting cells. J Immunol 1992;149: 661-667.
5. Hohlfeld R, and Engel AG: The immunobiology of muscle. Immunol Today 1994;15:269-274.
6. Huang J, Cao Y, Du J, Bu X, Ma R, and Wu C: Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses. Vaccine 2007;25:6981-6991.
7. Huang J, Ma R, and Wu CY: Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. Vaccine 2006;24:4905-4913.
8. Huang JH, Getty RR, Chisari FV, Fowler P, Greenspan NS, and Tykocinski ML: Protein transfer of preformed MHCpeptide complexes sensitizes target cells to T cell cytolysis. Immunity 1994;1:607-613.
9. JinH, Xiao C, Chen Z, et al.: Induction of Th1 type response by DNA vaccinations with N,M, and E genes against SARS-CoV in mice. Biochem Biophys Res Commun 2005;328:979-986.
10. June CH, Bluestone JA, Nadler LM, and Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994;15: 321-331.
11. Ksiazek TG, Erdman D, Goldsmith CS, S. et al.: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-1966.
12. Kwon B, Lee HW, and Kwon BS: New insights into the role of 4-1BB in immune responses: beyond CD8+ T cells. Trends Immunol 2002;23:378-380.
13. Lai MM: SARS virus: the beginning of the unraveling of a new coronavirus. J Biomed Sci 2003;10:664-675.
14. Liu S, Foster BA, Chen T, Zheng G, and Chen A: Modifying dendritic cells via protein transfer for antitumor therapeutics. Clin Cancer Res 2007;13:283-291.
15. Marra MA, Jones SJM, Astell CR, et al.: The genome sequence of the SARS-associated coronavirus. Science 2003; 300:1399-1404.
16. McShane H, Brookes R, Gilbert SC, and Hill AVS: Enhanced immunogenicity of CD4+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara primeboost vaccination regimen for murine tuberculosis. Infect Immun 2001;69:681-686.
17. O'Hagan D, Singh M, Ugozzoli M, et al.: Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. J Virol 2001; 75:9037-9043.
18. Peiris JS, Lai ST, Poon LL, et al.: Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361: 1319-1325.
19. Rota PA, Oberste MS, Monroe SS, et al.: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-1399.
20. Saoulli K, Lee SY, Cannons JL, et al.: CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med 1998;187:1849-1862.
21. Sato H, Masuda M, Kanai M, Tsukiyama-Kohara K, Yoneda M, and Kai C: Measles virus N protein inhibits host translation by binding to eIF3-p40. J Virol 2007;81:11569-11576.
22. Schirmbeck R, Zheng X, Roggendorf M, Geissler M, Chisari FV, Reimann J, and Lu M: Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J Immunol 2001;166:1405-1413.
23. Skowronski DM, Astell C, Brunham RC, et al.: Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 2005;56:357-381.
24. Tykocinski ML, Shu HK, Ayers DJ, et al.: Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 30 end sequence of decay-accelerating factor's mRNA. Proc Natl Acad Sci USA 1988;85:3555-3559.
25. Webster RG, Fynan EF, Santoro JC, and Robinson H: Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 1994;12:1495-1498.
26. Woo PC, Lau SK, Tsoi HW, et al.: SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine 2005;23:4959-4968.
27. Zheng G, Chen A, Sterner RE, Zhang PJ, Pan T, Kiyatkin N, and Tykocinski ML: Induction of antitumor immunity via intratumoral tetra-costimulator protein transfer. Cancer Res 2001;61:8127-8134.
28. Zheng G, Liu S, Wang P, Xu Y, and Chen A: Arming tumorreactive T cells with costimulator B7-1 enhances therapeutic efficacy of the T cells. Cancer Res 2006;66:6793-6799.
29. Zheng G, Wang B, and Chen A: The 4-1BB costimulation augments the proliferation of CD4+ CD25+ regulatory T cells. J Immunol 2004;173:2428-2434.
30. Zhu MS, Pan Y, Chen HQ, Shen Y, Wang XC, Sun YJ, and Tao KH: Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol Lett 2004;92:237-243.